Coya Therapeutics, Inc. (COYA) vs MaxCyte, Inc. (MXCT)
A side-by-side comparison of Coya Therapeutics, Inc. and MaxCyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COYA
Coya Therapeutics, Inc.
$5.00HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
MXCT
MaxCyte, Inc.
$1.06HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — COYA vs MXCT
growth of $100 · dividends reinvested · last 4yCOYA +6.1% (+1.5%/yr)MXCT -78.2% (-31.7%/yr)COYA compounded faster over this window
COYA MXCT
COYA vs MXCT: by the numbers
- •COYA is the larger company ($117M vs $113M market cap).
- •Both run net losses; MXCT's is the smaller (-114.77% vs -270.22% net margin).
Metrics side by side
Valuation
| Metric | COYA | MXCT |
|---|---|---|
| P/S ratio | 14.63 | 3.64 |
| P/B ratio | 0.00 | 0.71 |
Profitability
| Metric | COYA | MXCT |
|---|---|---|
| Gross margin | 99.91% | 79.43% |
| Operating margin | -255.05% | -137.12% |
| Net margin | -270.22% | -114.77% |
| ROE | -0.05% | -22.45% |
| ROIC | -0.05% | -19.83% |
Growth (annualized)
| Metric | COYA | MXCT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 1.46% |
| Total return CAGR (5Y) | N/A | -37.32% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.